DYMELOR Drug Patent Profile
✉ Email this page to a colleague
When do Dymelor patents expire, and what generic alternatives are available?
Dymelor is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in DYMELOR is acetohexamide. There are six drug master file entries for this compound. Additional details are available on the acetohexamide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DYMELOR?
- What are the global sales for DYMELOR?
- What is Average Wholesale Price for DYMELOR?
Summary for DYMELOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 77 |
Clinical Trials: | 1 |
Patent Applications: | 4,648 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DYMELOR at DailyMed |
![DYMELOR drug patent expirations Drug patent expirations by year for DYMELOR](/p/graph/s/t/DYMELOR-patent-expirations.png)
Recent Clinical Trials for DYMELOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Novartis | Phase 2 |
US Patents and Regulatory Information for DYMELOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | DYMELOR | acetohexamide | TABLET;ORAL | 013378-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | DYMELOR | acetohexamide | TABLET;ORAL | 013378-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |